Reply: Injectable products considered “samples”  

Oleh:

Lam, Charlene ; Crites, Joshua S. ; Clarke, Jennie T. ; Miller, Jeffrey J. ; Kirby, Joslyn S.

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: JAAD: Journal of the American Academy of Dermatology (keterangan: ada di ClinicalKey) vol. 72 no. 01 (Jan. 2015), page 198–199 .

Ketersediaan

Perpustakaan FK Nomor Panggil: J15.K Non-tandon: tidak ada Tandon: 1

Lihat Detail Induk

Isi artikel

We would like to thank Ms Dhossche and Drs Brodell and Ward for their thoughtful reply. We also appreciate the opportunity to briefly discuss the issue of drug sampling and the equivalency of dermal filler and botulinum products to oral prescription drugs, because these are typically considered “samples.” Drug sampling is a controversial issue. Increasingly, academic centers have rejected this practice because drug samples can potentially bias clinical decision-making and compromise patient care.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali